CN113230355A - 一种治疗高血压脑血管意外的中药合剂及其制备方法 - Google Patents
一种治疗高血压脑血管意外的中药合剂及其制备方法 Download PDFInfo
- Publication number
- CN113230355A CN113230355A CN202110666060.7A CN202110666060A CN113230355A CN 113230355 A CN113230355 A CN 113230355A CN 202110666060 A CN202110666060 A CN 202110666060A CN 113230355 A CN113230355 A CN 113230355A
- Authority
- CN
- China
- Prior art keywords
- mixture
- traditional chinese
- chinese medicine
- preparation
- cerebrovascular accident
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 29
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 27
- 208000006011 Stroke Diseases 0.000 title claims abstract description 21
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000001631 hypertensive effect Effects 0.000 title claims description 13
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 13
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 241000185686 Apocynum venetum Species 0.000 claims abstract description 10
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 10
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 10
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 10
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 9
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 9
- 241000157352 Uncaria Species 0.000 claims abstract description 9
- 235000008113 selfheal Nutrition 0.000 claims abstract description 9
- 235000003365 Ilex pubescens Nutrition 0.000 claims abstract description 8
- 241001100932 Ilex pubescens Species 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 7
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 241001412225 Firmiana simplex Species 0.000 claims abstract description 7
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 7
- 240000000249 Morus alba Species 0.000 claims abstract description 7
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 7
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 241001070186 Salsola collina Species 0.000 claims abstract description 7
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 6
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 6
- 240000008881 Oenanthe javanica Species 0.000 claims abstract description 6
- 235000000365 Oenanthe javanica Nutrition 0.000 claims abstract description 6
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 6
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 4
- 239000007788 liquid Substances 0.000 claims description 15
- 239000011812 mixed powder Substances 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000003765 sweetening agent Substances 0.000 claims description 6
- 244000211187 Lepidium sativum Species 0.000 claims description 5
- 235000007849 Lepidium sativum Nutrition 0.000 claims description 5
- 241000243684 Lumbricus Species 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 3
- 240000007890 Leonurus cardiaca Species 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000036772 blood pressure Effects 0.000 abstract description 10
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 241000218628 Ginkgo Species 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 206010010904 Convulsion Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 8
- 208000012886 Vertigo Diseases 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000036461 convulsion Effects 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 231100000889 vertigo Toxicity 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 201000009240 nasopharyngitis Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 241000207925 Leonurus Species 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003143 atherosclerotic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000033386 Buerger disease Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010023845 Laryngeal oedema Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000005978 brain dysfunction Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000002091 Febrile Seizures Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 208000009443 Vascular Malformations Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010053649 Vascular rupture Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 230000002892 effect on hypertension Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 206010016284 febrile convulsion Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000009939 hypertensive encephalopathy Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000009160 urethral calculus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗高血压脑血管意外的中药合剂及其制备方法,所述合剂由以下重量份的原料药制成:罗布麻5克、豨签草12克、丹参9克、丹皮6克、钩藤12克、怀牛膝12克、夏枯草15克、益母草15克、赤芍9克、猪毛菜10克、菊花9克、桑叶10克、茯苓12克、银杏叶10克、桃仁9克、毛冬青10克、决明子15克、泽泻6克、水芹10克、梧桐叶9克、地龙6克、天麻9克。本发明的组合物通过上述几种原料的配伍,通过多种作用基理发挥功效,并且在多种功效之间产生协同效应,在降血压、降血脂方面都具有显著效果,可以用于预防和治疗心脑血管疾病。
Description
技术领域
本发明涉及中药技术领域,尤其涉及一种治疗高血压脑血管意外的中药合剂及其制备方法。
背景技术
高血压或脑血管疾病的分类、病因:病机或发病机五里的分类(CVD)是脑血管疾病变化导致脑功能障碍的一类疾病的总称。高血压脑病,引走脑动脉便化,脑梗塞,脑血栓形成1、神经学说:2、肾原学说:3、内分泌学说。病理:早期周身细,1、心,血压增高后在心塞负荷加重,2、脑,脑小动脉硬化常见。3、肾、肾细小动脉硬化,它包括血管腔闭塞或狭窄、血管破裂,血管畸形,血管壁损伤或通透性发生改变等各种脑血管疾病引起的局限性或慢性脑功能障碍,但不包括血流动力学异常等因素导致的全脑缺血或氧所引起的弥漫性脑功能障碍,脑卒中,祖国医学、肝风,“眩晕”,头痛的范畴。多见于心情失调,饮食不节,内伤虚损等因素,导致人体,阴阳消化失调。尤其是肝肾阴阳失调所致。肝经失调之状苦肝阳上亢,见头痛,头晕,头错,恶心呕吐,咳嗽,咳痰,眩晕,耳鸣等,肝火上冲小便短黄,见面红目赤,善怒,易惊等,肝见入络,见四肢麻木,口眼歪斜,肝阳暴张夹座,夹头蒙闭清窍,走窜经络,见卒然昏仆,习饮 半身不遂等。肾经失调之候,苦肾阴亏损,见心,悸,不寐,五心,烦热,腰膝酸软等,肾阳之足,见便溏,肢冷,足付肿,阳萎等。
近年来随着大规模抗高血压、脑血管疾病脑血管疾病临床试验的开展和研究,对高血压、脑血管疾病脑血管疾病的有了新的认识。虽然在医学临床疗效上和理论研究上比以前有了很大的进步,降血压和治疗脑血管疾病的药很多,但多数药物对代谢器官有损害,限制了临床应用,而且有一定的副作用,治愈率低,对患者起不了控制的作用。
发明内容
本发明目的就是为了弥补已有技术的缺陷,提供一种治疗高血压脑血管意外的中药合剂及其制备方法。
本发明是通过以下技术方案实现的:
一种治疗高血压脑血管意外的中药合剂,所述合剂由以下重量份的原料药制成:
罗布麻3-7克、豨签草10-14克、丹参7-11克、丹皮4-8克、钩藤10-14克、怀牛膝10-14克、夏枯草13-17克、益母草13-17克、赤芍7-11克、猪毛菜8-12克、菊花7-11克、桑叶8-12克、茯苓10-14克、银杏叶8-12克、桃仁7-11克、毛冬青8-12克、决明子13-17克、泽泻4-8克、水芹8-12克、梧桐叶7-11克、地龙4-8克、天麻7-11克。
所述合剂由以下重量份的原料药制成:
罗布麻5克、豨签草12克、丹参9克、丹皮6克、钩藤12克、怀牛膝12克、夏枯草15克、益母草15克、赤芍9克、猪毛菜10克、菊花9克、桑叶10克、茯苓12克、银杏叶10克、桃仁9克、毛冬青10克、决明子15克、泽泻6克、水芹10克、梧桐叶9克、地龙6克、天麻9克。
一种治疗高血压脑血管意外的中药合剂的制备方法,具体包括以下步骤:
(1)称取罗布麻、丹参、钩藤、夏枯草、赤芍、菊花、水芹、豨签草、丹皮、怀牛膝、天麻、决明子、地龙混合后粉碎过40-60目筛,得混合粉一备用;
(2)再分别称取猪毛菜、桑叶、毛冬青、泽泻、梧桐叶、茯苓、桃仁、益母草、银杏叶,均匀喷洒少量蜂蜜水,闷10-15 分钟后文火翻炒至不粘手时取出,自然冷却后粉碎研细过80-100 目筛,得混合粉二备用;
(3)将混合粉一和混合粉二混合加入6-10 倍质量的水中,分三阶段通过微波加压进行提取药液,过滤得到提取液,药渣备用;
(4)将步骤(3)的药渣倒入煮药锅中,加入3-6倍质量水,浸泡20-30分钟后先加热至沸腾,再以文火煎煮60-120分钟,之后过滤得到药液备用;
(5)将步骤(3)所得提取液和步骤(4)所得药液混合送入煮药锅中,加热搅拌浓缩,得到浓缩药液,降温到常温后称量装瓶,即得本发明合剂。
所述步骤(5)中浓缩时控制每毫升药液相当于含有中药原料1-3克。
所述步骤(5)中降至常温后可以向其中加入甜味剂。
所述甜味剂为菊糖芽,加入量为0.2-0.5%。
本发明所用中药中:
豨签草苦,寒。归肝、肾经。具有祛除风湿,强健筋骨,清热解毒的功效。
益母草归肝、心包、膀胱经。活血调经,利尿消肿,清热解毒。用于月经不调,痛经经闭,恶露不尽,水肿尿少,疮疡肿毒。
罗布麻平肝安神,清热利水。用于肝阳眩晕,心悸失眠,浮肿尿少;高血压病,神经衰弱,肾炎浮肿。
丹皮,有镇静、降温、解热、镇痛、解痉等中枢抑制作用及抗动脉粥样硬化、利尿、抗溃疡等作用。
猪毛菜具有平肝潜阳,润肠通便之功效。用于高血压病,头痛,眩晕,肠燥便秘。
丹参,具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效。用于胸痹心痛,脘腹胁痛,症瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
怀牛膝含有大量生物碱,其功能可以补肝益肾、强壮筋骨、通经络、散恶血,适用于:三高(高血脂、高血压、高胆固醇)人群;欲改善肝功能者(各类肝炎、脂肪肝、肝硬化患者);免疫力低下、体质虚弱、易感冒人群;体内缺乏锌、锰的青少年及成年人士;欲预防骨质疏松,骨软化,肌肉抽搐,痉挛的人士; 胆、肾、膀胱、尿道结石患者;延缓衰老者。
桑叶归肺、肝经。疏散风热,清肺润燥,平肝明目,凉血止血。主治风热感冒,温病初起,肺热咳嗽,肝阳上亢眩晕,目赤昏花,血热妄行之咳血、吐血。
钩藤归肝、心包经。息风定惊,清热平肝。治高血压,头晕目眩,神经性头痛。用于肝风内动,惊痫抽搐,高热惊厥,感冒夹惊,小儿惊啼,妊娠子痫,头痛眩晕。
银杏叶,敛肺,平喘,活血化瘀,止痛。用于肺虚咳喘;冠心病,心绞痛,高血脂,抗凝固,有一定概率提高记忆力。银杏叶能促进血液循环,预防心血管病,银杏提取物为浓缩颗粒状,具有很强的清除自由基和抗氧化作用,银杏叶中的黄酮甙、氨基酸和氨基酸合成胶原蛋白成份对人体美容,抑制黑色素生长,保持皮肤光泽与弹性起着不小的作用。
夏枯草清肝泻火,明目,散结消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,乳痈,乳癖,乳房胀痛。
毛冬青清热解毒,活血通脉。治风热感冒,肺热喘咳,喉头水肿,扁桃体炎,痢疾,冠心病,脑血管意外所致的偏瘫,血栓闭塞性脉管炎,丹毒,烫伤,中心性视网膜炎,葡萄膜炎,以及皮肤急性化脓性炎症。用于冠状动脉硬化性心脏病、急性心肌梗塞、血柱闭塞性脉管炎。
赤芍清热凉血,散瘀止痛。用于热入营血,温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,瘾瘕腹痛,跌扑损伤,痈肿疮疡。
决明子,味苦、甘、咸,性微寒,入肝、肾、大肠经;润肠通便,降脂明目,治疗便秘及高血脂,高血压。清肝明目,利水通便,有缓泻作用,降血压降血脂。
菊花,归肺、肝经。散风清热,平肝明目,清热解毒。
天麻,味甘,性平;归肝经。主治:息风止痉,平抑肝阳,祛风通络;肝风内动,惊痫抽搐,本品主入肝经,功能息风止痉,且味甘质润,药性平和,故可用治各种病因之肝风内动,惊痫抽搐,不论寒热虚实,皆可配伍应用;眩晕,头痛:本品既息肝风,又平肝阳,为治眩晕、头痛之要药。不论虚证、实证,随不同配伍皆可应用;肢体麻木,手足不遂,风湿痹痛:本品又能祛外风,通经络,止痛。用治中风手足不遂,筋骨疼痛;妇人风痹,手足不遂;风湿痹痛,关节屈伸不利等。
茯苓为多孔菌科植物茯苓的干燥菌核,性温,味淡,入心、脾、肺经,渗湿利水,益脾和胃,宁心安神。
泽泻味甘、淡,性寒;归肾、膀胱经。具有利水渗湿,泄热通淋之功效。主治小便不利,热淋涩痛,水肿胀满,泄泻,痰饮眩晕,遗精。
桃仁,归心、肝、大肠经。活血祛瘀,润肠通便,止咳平喘。用于经闭痛经,症瘕痞块,肺痈肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。
地龙,具有清热定惊、通络、平喘、利尿的功效。常炒制后用于高热、神昏、惊痫抽搐、关节痹痛、肺热喘咳、尿少水肿、高血压等症。
水芹,味甘辛、性凉,入肺、胃经,有清热解毒、润肺利湿的功效,对发热感冒、呕吐腹泻、尿路感染、崩漏、水肿、高血压等有辅助疗效。
梧桐叶,具有祛风除湿,解毒消肿,降血压之功效。常用于风湿痹痛,跌打损伤,痈疮肿毒,痔疮,小儿疳积,泻痢,高血压病。
本发明的优点是:本发明中,毛冬青清热解毒,活血通脉。治风热感冒,肺热喘咳,喉头水肿,扁桃体炎,痢疾,冠心病,脑血管意外所致的偏瘫;水芹,味甘辛、性凉,入肺、胃经,有清热解毒、润肺利湿的功效,对发热感冒、呕吐腹泻、尿路感染、崩漏、水肿、高血压等有辅助疗效;组合物通过上述几种原料的配伍,通过多种作用基理发挥功效,并且在多种功效之间产生协同效应,在降血压、降血脂方面都具有显著效果,可以用于预防和治疗心脑血管疾病。本发明的中药由纯中药精制而成,不但通脉活血,行气化瘀,利水消肿,对高血压脑血管意外有很好的治疗作用,且无副作用。
具体实施方式
一种治疗高血压脑血管意外的中药合剂,所述合剂由以下重量份的原料药制成:
罗布麻5克、豨签草12克、丹参9克、丹皮6克、钩藤12克、怀牛膝12克、夏枯草15克、益母草15克、赤芍9克、猪毛菜10克、菊花9克、桑叶10克、茯苓12克、银杏叶10克、桃仁9克、毛冬青10克、决明子15克、泽泻6克、水芹10克、梧桐叶9克、地龙6克、天麻9克。
一种治疗高血压脑血管意外的中药合剂的制备方法,具体包括以下步骤:
(1)称取罗布麻、丹参、钩藤、夏枯草、赤芍、菊花、水芹、豨签草、丹皮、怀牛膝、天麻、决明子、地龙混合后粉碎过40-60目筛,得混合粉一备用;
(2)再分别称取猪毛菜、桑叶、毛冬青、泽泻、梧桐叶、茯苓、桃仁、益母草、银杏叶,均匀喷洒少量蜂蜜水,闷10-15 分钟后文火翻炒至不粘手时取出,自然冷却后粉碎研细过80-100 目筛,得混合粉二备用;
(3)将混合粉一和混合粉二混合加入6-10 倍质量的水中,分三阶段通过微波加压进行提取药液,过滤得到提取液,药渣备用;
(4)将步骤(3)的药渣倒入煮药锅中,加入3-6倍质量水,浸泡20-30分钟后先加热至沸腾,再以文火煎煮60-120分钟,之后过滤得到药液备用;
(5)将步骤(3)所得提取液和步骤(4)所得药液混合送入煮药锅中,加热搅拌浓缩,得到浓缩药液,降温到常温后称量装瓶,即得本发明合剂。
所述步骤(5)中浓缩时控制每毫升药液相当于含有中药原料1-3克。
所述步骤(5)中降至常温后可以向其中加入甜味剂。
所述甜味剂为菊糖芽,加入量为0.2-0.5%。
本发明的服用方法及服用量为;
每日两次,早晚各服用一次,每次10ml,两个月为一个疗程,一般服用2个疗程可痊愈。
本发明可有效治疗高血压及心脑血管意外的良药,经数千名患者临床服用,证明疗效显著,本发明可降低血脂和血粘度,能有效清除血液中的有毒物质及血管内壁凝结的血栓(斑块),减少血管阻力,确保血液畅通,防止动脉硬化,可增强血管弹性,软化血管,避免发生心脑梗塞或供血不足等症状,平稳降压,有效防止复发。不需长期服药,一般服药两月,病情减轻,服用四月,血压达到正常,肌体功能恢复,病症消除。
经临床对不同年龄段的60名高血压及心脑血管疾病患者服用效果统计显示如下:
60岁及以上患者25名,其中男16名,女9名,20年以上病史患者男5名,女2名,10-20年病史患者男6名,女4名,10年以下病史患者男5名,女3名,服用2个疗程后,25名全部有效,其中20名血压恢复正常,至今无反复。
40岁至59岁患者20名,其中男12名,女 8名,10年以上病史患者男8名,女5名,10年以下病史患者男4名,女3名,服用1-2个疗程后25名全部见效,其中18名血压恢复正常至今无反复。
40岁以下患者10名,其中男8名,女7名,病史一般3-5年,服药一个疗程后全部见效,服药后血压恢复正常至今无反复。
Claims (6)
1.一种治疗高血压脑血管意外的中药合剂,其特征在于:所述合剂由以下重量份的原料药制成:
罗布麻3-7克、豨签草10-14克、丹参7-11克、丹皮4-8克、钩藤10-14克、怀牛膝10-14克、夏枯草13-17克、益母草13-17克、赤芍7-11克、猪毛菜8-12克、菊花7-11克、桑叶8-12克、茯苓10-14克、银杏叶8-12克、桃仁7-11克、毛冬青8-12克、决明子13-17克、泽泻4-8克、水芹8-12克、梧桐叶7-11克、地龙4-8克、天麻7-11克。
2.根据权利要求1所述的一种治疗高血压脑血管意外的中药合剂,其特征在于:所述合剂由以下重量份的原料药制成:
罗布麻5克、豨签草12克、丹参9克、丹皮6克、钩藤12克、怀牛膝12克、夏枯草15克、益母草15克、赤芍9克、猪毛菜10克、菊花9克、桑叶10克、茯苓12克、银杏叶10克、桃仁9克、毛冬青10克、决明子15克、泽泻6克、水芹10克、梧桐叶9克、地龙6克、天麻9克。
3.一种治疗高血压脑血管意外的中药合剂的制备方法,其特征在于:具体包括以下步骤:
(1)称取罗布麻、丹参、钩藤、夏枯草、赤芍、菊花、水芹、豨签草、丹皮、怀牛膝、天麻、决明子、地龙混合后粉碎过40-60目筛,得混合粉一备用;
(2)再分别称取猪毛菜、桑叶、毛冬青、泽泻、梧桐叶、茯苓、桃仁、益母草、银杏叶,均匀喷洒少量蜂蜜水,闷10-15 分钟后文火翻炒至不粘手时取出,自然冷却后粉碎研细过 80-100 目筛,得混合粉二备用;
(3)将混合粉一和混合粉二混合加入6-10 倍质量的水中,分三阶段通过微波加压进行提取药液,过滤得到提取液,药渣备用;
(4)将步骤(3)的药渣倒入煮药锅中,加入3-6倍质量水,浸泡20-30分钟后先加热至沸腾,再以文火煎煮60-120分钟,之后过滤得到药液备用;
(5)将步骤(3)所得提取液和步骤(4)所得药液混合送入煮药锅中,加热搅拌浓缩,得到浓缩药液,降温到常温后称量装瓶,即得本发明合剂。
4.根据权利要求3所述的一种治疗高血压脑血管意外的中药合剂的制备方法,其特征在于:所述步骤(5)中浓缩时控制每毫升药液相当于含有中药原料1-3克。
5.根据权利要求3所述的一种治疗高血压脑血管意外的中药合剂的制备方法,其特征在于:所述步骤(5)中降至常温后可以向其中加入甜味剂。
6.根据权利要求5所述的一种治疗高血压脑血管意外的中药合剂的制备方法,其特征在于:所述甜味剂为菊糖芽,加入量为0.2-0.5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110666060.7A CN113230355A (zh) | 2021-06-16 | 2021-06-16 | 一种治疗高血压脑血管意外的中药合剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110666060.7A CN113230355A (zh) | 2021-06-16 | 2021-06-16 | 一种治疗高血压脑血管意外的中药合剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113230355A true CN113230355A (zh) | 2021-08-10 |
Family
ID=77140046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110666060.7A Withdrawn CN113230355A (zh) | 2021-06-16 | 2021-06-16 | 一种治疗高血压脑血管意外的中药合剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113230355A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113652863A (zh) * | 2021-08-26 | 2021-11-16 | 王海 | 一种具有保健养生、调理高血压的保健内衣及其生产方法 |
-
2021
- 2021-06-16 CN CN202110666060.7A patent/CN113230355A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113652863A (zh) * | 2021-08-26 | 2021-11-16 | 王海 | 一种具有保健养生、调理高血压的保健内衣及其生产方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110638967A (zh) | 一种益气、补肾、健脾、活血、通络的中药 | |
CN103599496A (zh) | 一种治疗慢性胃炎的中药 | |
CN113230355A (zh) | 一种治疗高血压脑血管意外的中药合剂及其制备方法 | |
CN107007784B (zh) | 用于逆转Aβ淀粉样蛋白损伤神经细胞的中药组合物及其制备方法与应用 | |
CN107320631B (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN110840978A (zh) | 一种治疗风湿、类风湿关节炎的中药组合物及其药酒 | |
CN108261506B (zh) | 一种治疗脱发的药物 | |
CN113521202A (zh) | 一种治疗高血压脑血管意外的中药合剂及其制备方法 | |
CN105031595A (zh) | 一种治疗钱币状湿疹的中药片剂及其制备方法 | |
CN111265609A (zh) | 一种辅助治疗真性近视的中药组合物及其制备方法 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN113633725A (zh) | 一种治疗高血压脑血管意外的中药合剂及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104825991A (zh) | 一种用于酒精中毒性精神障碍的中药制剂及制备方法 | |
CN104147573A (zh) | 治疗风感头痛的清热解毒制剂及制法 | |
CN116459314B (zh) | 一种延缓衰老喷剂 | |
CN111084842B (zh) | 治疗肩周炎、颈椎病、腰椎间盘突出、骨性关节炎的外用中药组合物 | |
CN116870112B (zh) | 一种治疗变应性鼻炎的中药制剂 | |
CN105902971A (zh) | 一种用于血栓性外痔的中药制剂及其制备方法 | |
CN105770081A (zh) | 用于促进脑出血手术后愈合的组合物制剂及其制备方法 | |
CN116492427A (zh) | 一种治疗癫痫的药物 | |
CN118662599A (zh) | 一种治疗膝骨关节炎的中药内服方组合物及其制备方法 | |
CN105213975A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN110559406A (zh) | 一种治疗脑梗中风的中药 | |
CN115590936A (zh) | 一种保健药酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210810 |